Mycotopia Therapies, Inc.
TPIA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -99.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | 50% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -24,254% | -49.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -27,091% | -73.9% |
| EPS Diluted | -0.003 | 0.024 | -0.044 | -0.046 |
| % Growth | -111.2% | 154.8% | 3.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |